Most people think of testosterone as a "male" hormone. But women make it too, in smaller amounts, and it does real work in the female body. It feeds sexual desire, supports energy and mood, and helps maintain muscle and bone. When levels drop, some women notice it. Low libido. Flat energy. A sense that something is just off.
This guide explains what low testosterone looks like in women, how doctors test for it, and how low-dose testosterone therapy is used off-label, mostly for one specific problem: distressing low sexual desire after menopause. We'll keep the science honest. The evidence is real but narrow, and there's no testosterone product approved for women in the United States. That matters, and we'll explain why.
Quick Answer
- The only evidence-based use of testosterone in women is treating hypoactive sexual desire disorder (HSDD) — distressing low sexual desire — mainly in postmenopausal women, per the 2019 Global Consensus Position Statement endorsed by 11 medical societies.
- No FDA-approved testosterone product exists for women in the U.S. Doctors prescribe male formulations at roughly one-tenth the male dose, off-label, with blood monitoring.
- Benefits are modest and specific: better sexual desire, arousal, and satisfaction. Testosterone is not proven to fix fatigue, mood, "brain fog," bone loss, or weight in women.
- The goal is to stay in the normal premenopausal range (roughly 15–70 ng/dL total testosterone). Overdosing causes acne, unwanted hair growth, and voice changes — some of which don't reverse.
Medical disclaimer: This article is for education only and is not medical advice. Testosterone therapy in women is off-label and carries real risks. Talk to a qualified clinician — ideally a gynecologist, endocrinologist, or sexual-medicine specialist — before starting or changing any hormone therapy. Never use testosterone if you are pregnant or trying to conceive.
What Does Testosterone Actually Do in Women?
Testosterone is an androgen. Women produce it in the ovaries and adrenal glands, and the body also converts it from other hormones. The amounts are small — a healthy woman has roughly one-tenth to one-twentieth the testosterone a man has — but the hormone is still active.
In women, testosterone contributes to:
- Sexual desire and arousal. This is its best-documented role.
- Energy and sense of well-being.
- Muscle tone and bone density, working alongside estrogen.
- Body hair in the pubic and underarm areas.
Levels peak in a woman's 20s and decline slowly with age. By the time a woman reaches her 40s, her testosterone is often about half what it was at 21. There's no sharp "drop-off" at menopause the way estrogen falls — the ovaries keep making some testosterone even after periods stop. Removing both ovaries (surgical menopause), on the other hand, cuts testosterone roughly in half overnight.
The Endocrine Society and ten partner societies stress an important point: there is no proven "testosterone deficiency syndrome" in women. Low testosterone on a lab test does not, by itself, mean a woman needs treatment. Symptoms come first.
What Are the Symptoms of Low Testosterone in Women?
Here's the tricky part. The symptoms blamed on low testosterone — tiredness, low mood, low sex drive — overlap with dozens of other conditions. Low thyroid. Depression. Iron deficiency. Poor sleep. Stress. The natural hormone shifts of perimenopause and menopause.
Symptoms women and clinicians commonly link to low testosterone:
| Symptom | How common with low T | Better-proven cause to rule out first |
|---|---|---|
| Low sexual desire (distressing) | Most studied symptom | Relationship issues, depression, SSRIs, menopause |
| Reduced arousal or orgasm | Common complaint | Vaginal dryness (estrogen), medications |
| Fatigue / low energy | Often reported | Anemia, thyroid, sleep apnea, depression |
| Low mood, irritability | Sometimes reported | Depression, perimenopause, life stress |
| Loss of muscle tone | Possible | Aging, inactivity, low protein |
| "Brain fog" | Frequently claimed | Menopause, sleep loss, stress |
Notice the pattern. Only the sexual symptoms have solid evidence tying them to testosterone in women — and even then, treatment only helps when the low desire causes genuine distress. That distinction is the difference between a normal change and a treatable disorder called HSDD (hypoactive sexual desire disorder).
If your main complaint is fatigue or brain fog, testosterone is unlikely to be the answer, and the research backs that up. The 2019 Lancet meta-analysis found no clear benefit of testosterone on mood, energy, or cognition in women. We'll cover that below.
How Is Low Testosterone in Women Diagnosed?
Diagnosis starts with the conversation, not the blood test. A clinician asks whether you have distressing low sexual desire and rules out the usual suspects — depression, medication side effects (antidepressants are a big one), thyroid problems, vaginal dryness, and relationship factors.
Only then does blood testing come in, and it's used to set a safe dosing baseline, not to "diagnose deficiency."
What the blood tests measure
| Test | Why it's done | Notes |
|---|---|---|
| Total testosterone | Baseline before therapy; safety monitoring | Draw in the morning; use a sensitive/accurate assay (LC-MS/MS) |
| SHBG (sex hormone-binding globulin) | Affects how much testosterone is "free" | High SHBG (from oral estrogen, thyroid) lowers free T |
| Free testosterone (calculated) | Estimates the active fraction | Calculated from total T + SHBG; direct assays are unreliable |
A key warning from the ISSWSH 2021 guideline: there is no blood level of testosterone that diagnoses HSDD or predicts who will respond. Many women with "low" numbers feel fine, and some with "normal" numbers have symptoms. Standard (non-sensitive) testosterone assays are also notoriously inaccurate at the low female range. Use a lab that runs liquid chromatography–mass spectrometry (LC-MS/MS).
For more on reading hormone labs, our guide on free vs. total testosterone and SHBG walks through the numbers (it's written for men, but the assay concepts apply to everyone).
Normal testosterone ranges in women
These ranges vary by lab and assay, so treat them as a guide:
| Group | Approximate total testosterone |
|---|---|
| Premenopausal women (20s–30s) | ~15–70 ng/dL |
| Women ages 30–49 | ~27–40 ng/dL |
| Postmenopausal women | ~7–40 ng/dL |
| Adult men (for comparison) | ~300–1,000 ng/dL |
Source ranges drawn from the ISSWSH guideline and clinical references such as Cleveland Clinic. The therapy target is to keep a woman within her own premenopausal physiologic range — never above it.
What's the Evidence That Testosterone Therapy Works for Women?
This is where it pays to separate marketing from data. The strongest evidence comes from two landmark sources.
The 2019 Lancet meta-analysis. Islam and colleagues pooled 36 randomized controlled trials covering more than 8,000 women (Lancet Diabetes Endocrinol 2019). The findings were clear and limited:
- Testosterone significantly improved sexual function in postmenopausal women — more satisfying sexual events, more desire, more arousal, more orgasm, and less sexual distress.
- Testosterone showed no significant benefit for mood, well-being, body composition, bone, or cognitive performance.
- Non-oral routes (patch, gel, cream) had a neutral effect on cholesterol, while oral testosterone worsened the lipid profile.
The APHRODITE trial. This 52-week, placebo-controlled study of 814 postmenopausal women with HSDD tested a testosterone patch (NEJM 2008). The 300-microgram/day dose raised satisfying sexual events from a baseline gain of 0.7 (placebo) to 2.1 per four weeks. The lower 150-microgram dose didn't beat placebo. Unwanted hair growth was more common on the active patch (30% vs. 23%).
So the honest summary: testosterone modestly helps sexual desire and satisfaction in postmenopausal women with HSDD. That's it. It is not a fatigue cure, an energy booster, or an anti-aging therapy, and selling it that way runs ahead of the science.
What the benefit looks like in plain numbers
| Outcome (postmenopausal HSDD) | Effect of testosterone vs. placebo |
|---|---|
| Satisfying sexual events / month | About 1 extra event per month (APHRODITE 300 mcg) |
| Sexual desire score | Modest, statistically significant improvement |
| Sexual distress | Reduced |
| Mood / energy / cognition | No significant benefit |
| Lean body mass / strength | No significant benefit |
How Is Testosterone Therapy Dosed in Women?
Because no female product is FDA-approved, clinicians borrow male products and use a fraction of the dose. The guiding rule from the Global Consensus Statement: use formulations that keep blood testosterone in the normal premenopausal range, and monitor regularly.
| Formulation | Typical female off-label dose | Notes |
|---|---|---|
| Transdermal 1% gel (male product) | ~1/10 of a male packet/day (~5 mg testosterone) | Most common U.S. approach; apply to skin, rotate sites |
| Transdermal 1% cream (compounded or AndroFeme where available) | ~5 mg/day, up to 10 mg/day | AndroFeme is approved in Australia, not the U.S. |
| Testosterone patch (e.g., 300 mcg/day) | Studied in trials | Intrinsa was withdrawn; rarely available now |
The starting principle is roughly one-tenth the male starting dose. The target is the premenopausal range, not a "high-normal" male level, and absolutely not above the female range.
Routes that are NOT recommended
The guidelines are firm here, and this is where a lot of clinics go wrong:
- Pellets / implants: Not recommended. They routinely push levels into the supraphysiologic range, and you can't dial them back once inserted.
- Injections (IM): Not recommended for women. Doses are hard to fine-tune at the tiny amounts women need.
- Oral testosterone: Not recommended. It strains the liver and worsens cholesterol.
- Compounded "bioidentical" blends: Discouraged. The ISSWSH guideline says compounded products "cannot be recommended" because of inconsistent dosing and a lack of safety data. Pellets and high-dose compounded creams are common in "wellness" and "hormone optimization" clinics — and they're exactly what the evidence warns against.
If a clinic leads with pellets or megadose creams marketed for "energy" and "anti-aging," that's a red flag. Our piece on how to choose a TRT provider covers the same vetting logic.
How Is Testosterone Therapy Monitored in Women?
Monitoring is non-negotiable, because the line between "physiologic dose" and "too much" is thin. Here's the schedule the ISSWSH guideline lays out.
| When | What to check |
|---|---|
| Before starting | Total testosterone, SHBG, fasting lipids, liver function; review symptoms and rule out other causes |
| 3–6 weeks after starting | Total testosterone (confirm you're in the physiologic range, not above) |
| After any dose change | Recheck testosterone within ~6 weeks |
| Every 4–6 months once stable | Total testosterone + clinical check for androgen excess (acne, hair growth, hair loss) |
| At 6 months if no benefit | Stop. If there's no meaningful improvement by 6 months, discontinue therapy |
That last row matters. Testosterone for women is a trial of therapy, not a lifelong commitment by default. If it isn't helping desire within six months, the guidelines say stop.
What Are the Risks and Side Effects?
At correct physiologic doses, short-term side effects are usually mild. Problems show up when doses run high — which is common with pellets and compounded creams.
Androgenic side effects (dose-related)
| Side effect | Reversible? |
|---|---|
| Acne / oily skin | Usually reversible |
| Increased facial/body hair (hirsutism) | Usually reversible if caught early |
| Scalp hair thinning (male-pattern) | May not fully reverse |
| Voice deepening | Often permanent |
| Clitoral enlargement | Often permanent |
The permanent risks — voice changes and clitoral enlargement — are the main reason staying in the physiologic range matters so much. They're rare at proper doses and far more likely with pellets, injections, or megadose creams.
Longer-term safety: what we know and don't
- Breast cancer: The Lancet meta-analysis found no signal that transdermal testosterone increases breast cancer in the studied timeframe. But trials weren't long enough to settle long-term breast safety.
- Heart and metabolism: Non-oral testosterone is lipid-neutral. Oral testosterone lowers HDL ("good" cholesterol). Long-term cardiovascular safety data in women are still limited.
- Liver: A concern with oral forms, not transdermal.
The Endocrine Society's androgen therapy guideline and the Global Consensus Statement both stress that long-term safety beyond about two years is not established. That's an honest gap, not a scare tactic — it just means therapy should be deliberate and monitored.
Who should not use testosterone
- Pregnant women or those trying to conceive — testosterone can masculinize a female fetus. Absolute contraindication.
- Women with existing signs of androgen excess (significant acne, hirsutism, alopecia).
- Women on anti-androgen medications like finasteride.
- Hormone-sensitive cancer — requires specialist input before any consideration.
Testosterone vs. Other Treatments for Low Libido
Testosterone isn't the only option, and for many women it isn't the first one. Low desire is often multifactorial.
| Approach | Best for | Notes |
|---|---|---|
| Treat the real cause | Everyone | Fix sleep, swap an SSRI, treat vaginal dryness with local estrogen, address relationship issues |
| Vaginal/local estrogen | Pain or dryness driving low interest | First-line for genitourinary symptoms; very safe |
| Testosterone (off-label) | Postmenopausal HSDD after other causes ruled out | Modest benefit; monitor closely |
| Flibanserin (Addyi) | Premenopausal HSDD | FDA-approved for women; daily pill; alcohol cautions |
| Bremelanotide (Vyleesi) | Premenopausal HSDD | FDA-approved; on-demand injection |
Two of these — flibanserin and bremelanotide — are actually FDA-approved for HSDD in premenopausal women, while testosterone is not approved for women at all. That's worth knowing if you're premenopausal, since the strongest testosterone evidence is in postmenopausal women specifically.
How Much Does Testosterone Therapy Cost for Women?
Because it's off-label and rarely insured for women, you're usually paying out of pocket. Rough ranges in the U.S.:
| Item | Typical cost |
|---|---|
| Initial consult (sexual medicine / endocrine / gyn) | $150–$400 |
| Lab panel (testosterone, SHBG, lipids) | $50–$200 |
| Compounded testosterone cream (monthly) | $30–$90 |
| Male 1% gel used off-label (monthly) | $30–$100 |
| Follow-up visits + monitoring labs | $100–$300 per cycle |
Costs vary widely by clinic and region. To model your own numbers, try our TRT cost calculator. And before committing to any clinic, compare providers and check our provider directory for telehealth and in-person options that follow guideline-based dosing rather than pushing pellets.
How Do You Choose a Safe Clinic?
The off-label gray zone attracts both careful specialists and aggressive "optimization" mills. Use this checklist.
Green flags:
- Starts with a full symptom workup and rules out other causes
- Uses transdermal cream or gel at physiologic doses
- Draws baseline labs and monitors testosterone at 3–6 weeks, then every 4–6 months
- Sets a 6-month "does this help?" checkpoint
- Has a clinician credentialed in gynecology, endocrinology, or sexual medicine
Red flags:
- Leads with pellets, injections, or high-dose compounded creams
- Markets testosterone for "energy," "fat loss," or "anti-aging" in women
- Skips baseline labs or doesn't monitor levels
- Promises to push you to "optimal" (read: male-range) levels
- No physician involvement, just a sales funnel
The same vetting principles apply whether you're a man or a woman — see online TRT clinics: how to pick a legit one.
Frequently Asked Questions
Is testosterone therapy approved by the FDA for women? No. There is no FDA-approved testosterone product for women in the United States. Clinicians use male products off-label, at roughly one-tenth the male dose, to keep blood levels in the normal female range. This off-label status is why careful dosing and monitoring matter so much.
Will testosterone fix my fatigue or brain fog? Probably not. The largest analysis of trials found testosterone helps sexual desire and satisfaction but shows no proven benefit for energy, mood, or thinking in women. If fatigue is your main issue, get checked for thyroid problems, anemia, sleep apnea, depression, and perimenopause first.
Can premenopausal women take testosterone? The strongest evidence is in postmenopausal women. Guidelines extend cautiously to late-reproductive-age women with HSDD, but data are thinner. Premenopausal women with distressing low desire also have two FDA-approved options — flibanserin and bremelanotide — that testosterone lacks. Never use testosterone if you might become pregnant.
How long until I know if it's working? Give it a few months, but not forever. The ISSWSH guideline says if there's no meaningful improvement in sexual desire by six months, you should stop. Testosterone for women is a monitored trial, not an automatic lifelong therapy.
Are testosterone pellets safe for women? Guidelines specifically advise against pellets and injections in women. They tend to push levels too high and can't be adjusted once placed, raising the risk of acne, hair growth, and — at high enough levels — permanent voice deepening or clitoral enlargement. Transdermal cream or gel at low doses is the preferred route.
Related Guides
- Testosterone Levels by Age: Normal Ranges and What Counts as Low
- Free vs Total Testosterone and SHBG: How to Read Your Numbers
- TRT for Erectile Dysfunction and Low Libido: Does It Actually Help?
- How to Choose a TRT Provider: Telehealth vs. In-Person
- Online TRT Clinics: How They Work and How to Pick a Legit One
Sources
- Davis SR, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Sex Med. 2019. PMID 31488288
- Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019. PMID 31353194
- Parish SJ, et al. ISSWSH Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women. J Sex Med. 2021. PMID 33814355
- Davis SR, et al. Testosterone for low libido in postmenopausal women not taking estrogen (APHRODITE). N Engl J Med. 2008. PMID 18987368
- Wierman ME, et al. Androgen Therapy in Women: A Reappraisal — An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014. PMID 25279570
- Endocrine Society. Coalition Issues International Consensus on Testosterone Treatment for Women. 2019. endocrine.org
- Cleveland Clinic. Low Testosterone in Women: Symptoms and Causes. health.clevelandclinic.org
- International Menopause Society. Global Consensus Position Statement on the Use of Testosterone Therapy for Women (PDF). imsociety.org
Last reviewed June 2026. This guide is educational and not a substitute for personalized medical advice.